-
Product Insights
Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cytokine Release Syndrome (Cytokine Storm) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cytokine Release Syndrome (Cytokine Storm), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016" provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical trials on Sicca Syndrome (Sjogren). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Sarcoidosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H1, 2016" provides an overview of Sarcoidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcoidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Psoriasis - Current and Future Players
GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies and analyses the key companies shaping and driving the global Psoriasis market. The report provides insight into the competitive Psoriasis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house...
-
Sector Analysis
Psoriasis – US Drug Forecast and Market Analysis to 2024
Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for patients. GlobalData projects the Psoriasis market in 8MM to experience modest growth during the forecast period at a CAGR of 7.26%. This growth will be driven primarily by the highly anticipated arrivals of promising...
-
Sector Analysis
Psoriasis – Japan Drug Forecast and Market Analysis to 2024
Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for patients. GlobalData projects the Psoriasis market in 8MM to experience modest growth during the forecast period at a CAGR of 7.26%. This growth will be driven primarily by the highly anticipated arrivals of promising...
-
Sector Analysis
Psoriasis – India Drug Forecast and Market Analysis to 2024
Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not life-threatening, Psoriasis causes tremendous morbidity and personal angst for patients. GlobalData projects the Psoriasis market in 8MM to experience modest growth during the forecast period at a CAGR of 7.26%. This growth will be driven primarily by the highly anticipated arrivals of promising...
-
Product Insights
Angioedema Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H1, 2016" provides an overview of Angioedema clinical trials scenario. This report provides top line data relating to the clinical trials on Angioedema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Myasthenia Gravis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2016" provides an overview of Myasthenia Gravis clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia Gravis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2016" provides an overview of X-Linked Agammaglobulinemia clinical trials scenario. This report provides top line data relating to the clinical trials on X-Linked Agammaglobulinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.